در حال جستجو در محتوی

ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده: 4 مورد
نسخه الکترونیک
medimedia.ir
Treatment protocols for anal cancer
Treatment protocols for bladder and urinary tract cancers
Treatment protocols for breast cancer
Treatment protocols for castration-resistant prostate cancer
Treatment protocols for esophagogastric cancer
Treatment protocols for germ cell tumors
Treatment protocols for gynecologic malignancies
Treatment protocols for hepatobiliary cancer
Treatment protocols for kidney cancer
Treatment protocols for lymphoma
Treatment protocols for melanoma
Treatment protocols for multiple myeloma
Treatment protocols for non-small cell lung cancer
Treatment protocols for pancreatic cancer
Treatment protocols for small and large bowel cancer
Treatment protocols for small-cell carcinoma of the lung
Treatment protocols for soft tissue and bone sarcoma
Treatment protocols for squamous cell carcinoma of the head and neck
Bleomycin-induced lung injury
Busulfan-induced pulmonary injury
Cancer-related fatigue: Prevalence, screening, and clinical assessment
Cancer-related fatigue: Treatment
Cardiotoxicity of cancer chemotherapy agents other than anthracyclines, HER2-targeted agents, and fluoropyrimidines
Cardiotoxicity of trastuzumab and other HER2-targeted agents
Causes of anemia in patients with cancer
Chemotherapy and radiation-related hemorrhagic cystitis in cancer patients
Chemotherapy hepatotoxicity and dose modification in patients with liver disease: Conventional cytotoxic agents
Chemotherapy nephrotoxicity and dose modification in patients with kidney impairment: Conventional cytotoxic agents
Chemotherapy nephrotoxicity and dose modification in patients with kidney impairment: Molecularly targeted agents and immunotherapies
Chemotherapy-associated diarrhea, constipation and intestinal perforation: pathogenesis, risk factors, and clinical presentation
Chlorambucil-induced pulmonary injury
Cisplatin nephrotoxicity
Common terminology criteria for adverse events
Crystal-induced acute kidney injury
Cutaneous adverse effects of conventional chemotherapy agents
Cutaneous adverse events of molecularly targeted therapy and other biologic agents used for cancer therapy
Cyclophosphamide pulmonary toxicity
Differentiation syndrome associated with treatment of acute leukemia
Drug-induced thrombotic microangiopathy (DITMA)
Effects of cytotoxic agents on gonadal function in adult men
Extravasation injury from cytotoxic and other noncytotoxic vesicants in adults
General toxicity of cyclophosphamide in rheumatic diseases
Infusion reactions to systemic chemotherapy
Infusion-related reactions to therapeutic monoclonal antibodies used for cancer therapy
Management of menorrhagia during chemotherapy
Management of poorly controlled or breakthrough chemotherapy-induced nausea and vomiting in adults
Medication-related osteonecrosis of the jaw in patients with cancer
Methotrexate-induced lung injury
Mitomycin pulmonary toxicity
Neurologic complications of cancer treatment with molecularly targeted and biologic agents
Nitrosourea-induced pulmonary injury
Oral toxicity associated with systemic anticancer therapy
Overview of neurologic complications of conventional non-platinum cancer chemotherapy
Overview of neurologic complications of platinum-based chemotherapy
Pathophysiology and prediction of chemotherapy-induced nausea and vomiting
Prevention of chemotherapy-induced nausea and vomiting in adults
Prophylaxis of infection during chemotherapy-induced neutropenia in high-risk adults
Pulmonary toxicity associated with antineoplastic therapy: Cytotoxic agents
Pulmonary toxicity associated with antineoplastic therapy: Molecularly targeted agents
Pulmonary toxicity associated with systemic antineoplastic therapy: Clinical presentation, diagnosis, and treatment
Risks of therapy with bone antiresorptive agents in patients with advanced malignancy
Role of erythropoiesis-stimulating agents in the treatment of anemia in patients with cancer
Systemic chemotherapy for cancer in older adults
Taxane-induced pulmonary toxicity
Therapeutic use and toxicity of high-dose methotrexate
Toxic erythema of chemotherapy (hand-foot syndrome)
Toxicity of molecularly targeted antiangiogenic agents: Cardiovascular effects
Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects
Treatment-related toxicity in testicular germ cell tumors
Tumor lysis syndrome: Pathogenesis, clinical manifestations, definition, etiology and risk factors
Tumor lysis syndrome: Prevention and treatment
Use of granulocyte colony stimulating factors in adult patients with chemotherapy-induced neutropenia and conditions other than acute leukemia, myelodysplastic syndrome, and hematopoietic cell transplantation

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟